Since combined expression of GPC2 and CD276 is observed in 95% of neuroblastoma samples, these BiCisCAR T cells have specificity for a greater proportion of cancer cells compared to single target CAR T cells. This evidence concerns the gene GPC2 and neuroblastoma.